(1,3)-Beta-D-Glucan (Aspergillus) Lab Test

The (1,3)-Beta-D-Glucan (BDG) Lab Test from Lab Tests Dubai is a highly sensitive blood-based assay designed to detect (1,3)-β-D-glucan, a key component of fungal cell walls found in Aspergillus, Candida, Pneumocystis, and other pathogenic fungi—but not in bacteria or human cells.

This test plays a life-saving role in diagnosing invasive fungal infections (IFIs)—especially in immunocompromised patients such as those undergoing:

• Chemotherapy or stem cell transplantation
• Organ transplantation
• Long-term corticosteroid or immunosuppressive therapy
• ICU admission with prolonged ventilation

Using enzyme immunoassay (Fungitell® or equivalent) technology, this serum-based test helps clinicians:

• Detect fungal infection before cultures turn positive
• Initiate early antifungal therapy
• Monitor treatment response
• Reduce mortality from invasive aspergillosis, candidiasis, and PJP

Available with home blood collection and specialized handling, Lab Tests Dubai ensures accurate, timely, and stress-free testing—so high-risk patients can get the answers they need.

Why You Need This Test

If you or a loved one is immunocompromised and running a persistent fever, this test could detect a deadly fungal infection before it’s too late.

You need the (1,3)-Beta-D-Glucan Test if:

• You’re undergoing chemotherapy and have prolonged neutropenic fever
• You’ve had an organ or stem cell transplant
• You’re on long-term steroids or biologics (e.g., for autoimmune disease)
• You’re in the ICU with unexplained respiratory distress
• You have HIV/AIDS with low CD4 count (risk for Pneumocystis)
• You’re being evaluated for invasive candidiasis or aspergillosis

BDG is a “pan-fungal” biomarker—positive in:

• Invasive Aspergillosis
• Candidemia & invasive candidiasis
• Pneumocystis jirovecii pneumonia (PJP)
• Fusarium, Trichosporon, and other molds

This test is not diagnostic alone—but a critical early warning system.

Symptoms That Indicate This Test

Consider the BDG Test if you or a loved one experience:

• For Invasive Aspergillosis:

• Fever unresponsive to antibiotics

• Dry cough, shortness of breath, chest pain

• Coughing up blood (hemoptysis)

• Sinus pain or facial swelling (invasive fungal sinusitis)

• For Invasive Candidiasis:

• Fever, chills, septic shock

• Abdominal pain, jaundice (hepatosplenic candidiasis)

• Retinal lesions (endophthalmitis)

• For Pneumocystis (PJP):

• Progressive shortness of breath

• Dry cough, low oxygen saturation

• Crackles on lung exam

• High-Risk Conditions:

• Neutropenia (ANC <500)

• Recent transplant or ICU stay

• Use of central lines, TPN, or broad-spectrum antibiotics

These signs may indicate life-threatening fungal infection—and this test helps start treatment early.

Natural Production: Why BDG is a Fungal “Fingerprint”

(1,3)-Beta-D-Glucan is a polysaccharide found in the cell walls of most fungi, including:

• Aspergillus spp.
• Candida spp.
• Pneumocystis jirovecii
• Fusarium, Trichosporon, Saccharomyces

It is NOT produced by humans or bacteria, making its presence in blood a strong indicator of fungal invasion.

When fungi invade tissues, BDG is released into the bloodstream, where it can be detected days before cultures become positive.

Important Notes

• False positives can occur with:
  • IV immunoglobulin (IVIG), albumin
  • Bacterial sepsis (e.g., Pseudomonas)
  • Hemodialysis with cellulose membranes
  • Gauze or surgical sponges (contains glucan)
• False negatives in localized or early infection

Always interpret with imaging (CT), GM test (for Aspergillus), and clinical context.

What Happens If Untreated? Risks of Ignoring Fungal Infection

Ignoring a positive BDG result can lead to:

• Rapidly Progressive Invasive Aspergillosis – lung cavities, brain abscesses
• Candidemia & Septic Shock – mortality up to 40–60%
• PJP-Induced Respiratory Failure – fatal without treatment
• Disseminated Fungal Disease – liver, spleen, brain involvement
• Delayed Antifungal Therapy – worse outcomes

The good news? Early detection saves lives. Starting antifungals like:

• Voriconazole (for Aspergillus)
• Echinocandins (for Candida)
• Trimethoprim-sulfamethoxazole (for PJP)

…can dramatically improve survival.

How to Prepare for the Test

To ensure accurate results:

• No fasting required

• Avoid blood products, IVIG, or albumin 24–48 hours before (can cause false positives)

• Inform your doctor of:

• Current antifungal therapy (may lower BDG)

• Recent surgery or gauze use

• Dialysis or TPN use

• History of fungal infection or colonization

A serum blood sample is collected via standard draw—available at our labs or via home collection with contamination prevention.

Test Overview: Enzyme Immunoassay Method

Interpretation

Results are reported with clinical notes for your infectious disease specialist or oncologist.

Benefits of the (1,3)-Beta-D-Glucan Test

• Early Detection

Identify fungal infection before cultures or imaging show changes.

• Life-Saving Intervention

Start antifungals earlier, improving survival rates.

• Monitor Treatment Response

Declining BDG levels indicate effective therapy.

• Rule Out Fungal Cause

Helps avoid unnecessary antifungal use.

• Critical for Immunocompromised Patients

Essential in transplant, oncology, and ICU settings.

If you or a loved one is immunocompromised and unwell, the (1,3)-Beta-D-Glucan Test gives you the answers you need in 15 days—so you can start life-saving treatment early.